-
Mesothelioma Widow Accuses John Crane of Failure to Test Gaskets
A South Carolina judge and jury are hearing claims by a mesothelioma victim’s widow against John Crane, Inc. Melba Bolton is accusing the company of having recklessly exposed her late husband Curtis Bolton to gaskets and packing contaminated with asbestos during the years between 1971 and 1977 that he worked at the Celanese factory as
-
Airplane Mechanic’s Mesothelioma Death Blamed on Asbestos in Aircraft
John R. McCabe, Sr. was an Air Force veteran who spent years working at the Kennedy Space Center repairing aircraft of all kinds, and it was that work that exposed him to the asbestos that led to his death from malignant epithelioid mesothelioma. Though he died before his personal injury lawsuit could be heard, his
-
Research Organization Identifies Protein Linked to Mesothelioma Suppression
Putting an end to malignant mesothelioma is the goal of physicians and researchers around the world, but the rare, asbestos-related disease continues to be an unsolved puzzle. While surgeons and oncologists work to find effective treatment protocols for removing tumors and preventing them from coming back, scientists are working at a molecular level. A recent
-
Former Electrician’s Mesothelioma Blamed on Boilers
Former electrician Mr. Collin Bassier filed a personal injury lawsuit against multiple companies he blames for his malignant pleural mesothelioma. Specifically, he points to asbestos in the equipment that he worked near and with for his fatal illness. A boiler company named in his claim argued the case against them should be dismissed over part
-
Grateful for EPA Action, Mesothelioma Advocate Says “Work Remains”
For people diagnosed with malignant mesothelioma and other asbestos-related diseases, Monday’s news of the EPA’s final rule on chrysotile asbestos was a breath of fresh air. But even as she marks this important victory, the Asbestos Disease Awareness Organization’s Linda Reinstein is looking ahead to the work that remains.
-
Asbestos Ban Marks Historic Victory for Mesothelioma Advocates
For more than fifty years, mesothelioma and asbestos-related disease advocates have been fighting for a ban on the use of asbestos in the United States. After decades of pushback from the chemical industry and roadblocks imposed by previous administrations, the Environmental Protection Agency has finalized a rule prohibiting ongoing uses of the carcinogenic material.
-
New Lung Cancer Treatment May Hold Hope for Mesothelioma Too
A just-released study is offering encouragement to those diagnosed with small cell lung cancer and raising hopes among mesothelioma victims too. Scientists at UT Southwestern report finding that a specific molecule can damage DNA and halt the spread of the difficult-to-treat disease.
-
Hung Jury in J&J Talc/Asbestos Lawsuit Means New Trial Will Be Scheduled
After days of testimony, a Florida jury declared itself hopelessly deadlocked as to whether Johnson & Johnson’s Baby Powder was at fault for a Miami anesthesiologist’s death. The judge declared a mistrial and the case will be scheduled for a new trial shortly.
-
Mesothelioma Victims Argue Against Bestwall Bankruptcy Filing
Over the last several years, mesothelioma victims and others diagnosed with asbestos-related diseases have been faced with a legal challenge on top of their illnesses: the companies they blame for their asbestos-related diseases have used a controversial legal strategy known as a Texas Two-Step to file for bankruptcy in the state of Texas and avoid
-
Imperial College Researchers Identify New Mesothelioma Cell Targets
Malignant pleural mesothelioma is a highly aggressive cancer that is notoriously difficult to treat. Patients diagnosed with the rare asbestos-related disease generally six to 21 months after diagnosis, a survival rate that has not changed for decades. A group of researchers from the Imperial College in London investigated a novel approach to treating the disease
-
Mesothelioma Study Reveals Prognostic Potential for Clonal Gene Signatures
A study published in Nature’s new open-access journal NPJ Precision Oncology reports that researchers tested the prognostic value of a clonal gene signature from malignant pleural mesothelioma tumor samples and found them to have high prognostic values and reproducibility. The results suggest that the information will help physicians treating patients with the rare form of cancer will
-
Cancer Vaccine Test on Mesothelioma Patients Shows Promise
A Phase II clinical trial assessing the impact of adding a cancer vaccine to second-line immunotherapy treatment for pleural mesothelioma has revealed that the approach provides a significant benefit for patients. According to an announcement from clinical-stage biotechnology company Ultimovacs, the 118 pleural mesothelioma patients included in the study demonstrated a positive impact on both
-
State Supreme Court Denies Asbestos Company’s Appeal of Mesothelioma Decision
Eighteen months ago, South Carolina’s state Court of Appeals rejected an asbestos company’s appeal of a million-dollar mesothelioma award. Despite the reasoning provided by the justices and the evidence provided in court, the company took its argument to the state’s Supreme Court. Last week, those judges affirmed the court of appeals’ decision and allowed the
-
Lawsuit Sees J&J Chief Medical Officer Deny Ovarian Cancer & Mesothelioma Talc Cancer Claims
Over the last several years, tens of thousands of victims of ovarian cancer and malignant mesothelioma have pointed at talc in Johnson & Johnson’s Baby Powder as the cause of their illness. The lawsuits filed against the consumer giant accuse the company of knowing that the talc in their product was linked to cancer and
-
Appellate Court Agrees on Difference Between Asbestosis and Mesothelioma, Reverses Decision on Case
Both malignant mesothelioma and asbestosis are illnesses caused by exposure to asbestos, a deadly fiber with a long history of use in industrial, construction, and high-heat settings. The difference between the two illnesses was among the notable points at the forefront of a successful appeal heard recently in Texas.
-
Asbestos Company’s Appeal of $23 Million Mesothelioma Verdict Denied
Earlier this year, a New York jury awarded an 81-year-old mesothelioma victim $13 million for past pain and suffering and $10 million for future pain and suffering after hearing evidence of negligence on the part of valve manufacturer Jenkins Brothers. Though the company appealed the verdict and award, the Supreme Court of New York’s Appellate
-
Massachusetts AG Files Lawsuit Alleging Company Put Public and Employees at Risk of Mesothelioma
For decades, the world has understood asbestos’ role in the development of malignant mesothelioma, lung cancer, and other diseases. Despite this universal knowledge and countless people facing the realities of these painful asbestos-related illnesses, profit-focused companies continue defying protective regulations for asbestos management. In response to one such case, the attorney general of Massachusetts has
-
Study Shows Combination of Immunotherapy Drugs Offers Promise for Mesothelioma Patients
A combination of two immunotherapy drugs delivered an “encouraging” response rate in patients with advanced solid tumors, offering new hope for improvement in mesothelioma treatments. The clinical trial revealed a 37.7% objective response to treatment with anti-CTLA-4 human immunoglobulin (Ig) G1 monoclonal antibody CS1002 and the anti-PD-1 humanized recombinant IgG4 monoclonal antibody CS1003, also known
-
New Computer Lung Tissue Model Could Improve Mesothelioma Treatment
Radiation therapy is one of the protocols most frequently used to treat patients diagnosed with lung cancer and malignant pleural mesothelioma. Still, the powerful energy that the technology applies carries the risk of damaging healthy tissue. This is why a new study just published in the journal Communications Medicine is being met with such enthusiasm by doctors
-
Asbestos Defendants Face Off Against Each Other in Mesothelioma Lawsuit
One of the first steps in filing a mesothelioma lawsuit is identifying all the companies that exposed the victim to asbestos. In cases of workplace exposure, dozens of companies can be involved, and defendants often blame each other instead of accepting responsibility. In a recent case, Westinghouse Electric Corporation asked to be dropped from litigation,
